BCL6 and lymphoma: Both inhibitors and degradersof BCL6 have been shown to cause selective growth inhibition in BCL6-drivenlymphoma cell lines,8,9 but to date, the therapeutic potentialof inhibition or degradation of BCL6 in vivo in lymphomas has notbeen thoroughly tested.